Muscle Damage clinical trials

Explore recruiting muscle damage clinical trials.

Recruiting muscle damage studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Muscle Damage trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2 Randomized, Double-blind, Placebo-controlled Study of the Effect of EDG-5506 on Biomarker Response to Exercise in Adults with Becker Muscular Dystrophy, McArdle Disease, or Limb-Girdle Muscular Dystrophy

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Self-Assessment Method for Statin side-effects Or Nocebo 2

Denmark

Phase III and phase IV (Integrated) EU CTIS Study details

Muscle Damage trials by city

Muscle Damage in Toronto Muscle Damage in Vancouver Muscle Damage in Montreal Muscle Damage in Calgary Muscle Damage in Edmonton Muscle Damage in Ottawa Muscle Damage in Winnipeg Muscle Damage in Quebec City Muscle Damage in Hamilton Muscle Damage in Kitchener Muscle Damage in London Muscle Damage in Halifax Muscle Damage in New York Muscle Damage in Los Angeles Muscle Damage in Chicago Muscle Damage in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease